Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy

Ying Du, Qi Yan, Chuan Li, Wenping Zhu, Chao Zhao, Yunfeng Hao, Lin Li, Dan Yao, Xuan Zhou, Ying Li, Yuting Dang, Rong Zhang, Lin Han, Yuanyuan Wang, Tao Hou, Juan Li, Hailin Li, Panpan Jiang, Pei Wang, Fenying Chen, Tingge Zhu, Juntong Liu, Shuyu Liu, Lan Gao, Yingjun Zhao, Wei Zhang

Open source

DOI
10.1002/acn3.52270
Published
2024-12-11
Container
Annals of Clinical and Translational Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.52270,
  title = {Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy},
  author = {Ying Du and Qi Yan and Chuan Li and Wenping Zhu and Chao Zhao and Yunfeng Hao and Lin Li and Dan Yao and Xuan Zhou and Ying Li and Yuting Dang and Rong Zhang and Lin Han and Yuanyuan Wang and Tao Hou and Juan Li and Hailin Li and Panpan Jiang and Pei Wang and Fenying Chen and Tingge Zhu and Juntong Liu and Shuyu Liu and Lan Gao and Yingjun Zhao and Wei Zhang},
  year = {2024},
  journal = {Annals of Clinical and Translational Neurology},
  doi = {10.1002/acn3.52270},
  url = {https://doi.org/10.1002/acn3.52270}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy
AU  - Ying Du
AU  - Qi Yan
AU  - Chuan Li
AU  - Wenping Zhu
AU  - Chao Zhao
AU  - Yunfeng Hao
AU  - Lin Li
AU  - Dan Yao
AU  - Xuan Zhou
AU  - Ying Li
AU  - Yuting Dang
AU  - Rong Zhang
AU  - Lin Han
AU  - Yuanyuan Wang
AU  - Tao Hou
AU  - Juan Li
AU  - Hailin Li
AU  - Panpan Jiang
AU  - Pei Wang
AU  - Fenying Chen
AU  - Tingge Zhu
AU  - Juntong Liu
AU  - Shuyu Liu
AU  - Lan Gao
AU  - Yingjun Zhao
AU  - Wei Zhang
PY  - 2024
JO  - Annals of Clinical and Translational Neurology
DO  - 10.1002/acn3.52270
UR  - https://doi.org/10.1002/acn3.52270
ER  - 

APA

Du, Y., Yan, Q., Li, C., Zhu, W., Zhao, C., Hao, Y., Li, L., Yao, D., Zhou, X., Li, Y., Dang, Y., Zhang, R., Han, L., Wang, Y., Hou, T., Li, J., Li, H., Jiang, P., Wang, P., Chen, F., Zhu, T., Liu, J., Liu, S., Gao, L., Zhao, Y., & Zhang, W. (2024). Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52270

Source records